Conference
Impact of early identification of brain metastases in metastatic renal cell carcinoma (mRCC).
Abstract
620
Background: Up to one-third of patients with mRCC can present with asymptomatic brain metastases (BM). Timely identification of BM allows for the delivery of early local interventions, which may lead to improved patient outcomes. To investigate the potential utility of routine intra-cranial imaging, we compared the outcomes of mRCC patients with asymptomatic versus symptomatic BM. Methods: Using the Canadian Kidney Cancer …
Authors
Parmar A; Ghosh S; Lalani A-KA; Hansen AR; Reaume MN; Wood L; Basappa NS; Heng DYC; Graham J; Kollmannsberger CK
Volume
38
Pagination
pp. 620-620
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 20, 2020
DOI
10.1200/jco.2020.38.6_suppl.620
Conference proceedings
Journal of Clinical Oncology
Issue
6_suppl
ISSN
0732-183X